Germany offers tuition-free public universities and an 18-month work visa. Study Abroad: As the number of Indian students heading abroad for higher education continues to rise, visa delays and ...

An area chart showing ... ethnicities receive 3% of inheritance dollars, far less a share than they represent in the US population. (Stacker/Stacker) An Edward Jones study this year of about ...

A study conducted ... ethnicities received just 3% of inheritance dollars, representing two to four times less inheritance compared to their population size. In studying two decades of wealth ...

But for the second consecutive year, the Virginia legislature failed to fund the critically needed menhaden study. Unsurprisingly ... State Water Control Board. Column: We can still count on ...

But for the second consecutive year, the Virginia legislature failed to fund the critically needed menhaden study. Unsurprisingly, the foreign-owned company that pulls 112 million pounds of ...

As the US National Institutes of Health (NIH) continues to defund nearly every research project on transgender health, the White House has directed the agency to focus on studying “regret ...

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory agencies. The Food and Drug Administration (FDA), with Imunon Inc., has ...

≥ 3, and ≥ 4 lines of therapy, respectively. "This study shows that the real-world sequence of treatments in older patients with follicular lymphoma is heterogeneous. Despite improvement in ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease progression over 96 weeks of treatment, according to a phase 3 study ...

Now, a new study suggests that a simple supplement combination—including omega-3 and vitamin D—can help slow your biological age. Here’s what the study found, plus what a neurologist wants ...

The STEER study confirmed the therapy's favorable safety profile, with adverse events similar to the control group. OAV101 IT is a one-time gene therapy designed to replace the function of the ...